Charles Schwab Investment Management Inc Revolution Medicines, Inc. Transaction History

Charles Schwab Investment Management Inc

  • $515 Billion
  • Q3 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 1,763,117 shares of RVMD stock, worth $75.7 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,763,117
Previous 1,109,684 58.88%
Holding current value
$75.7 Million
Previous $43.1 Million 85.5%
% of portfolio
0.02%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$36.92 - $47.94 $24.1 Million - $31.3 Million
653,433 Added 58.88%
1,763,117 $79.9 Million
Q2 2024

Aug 12, 2024
BUY
$30.14 - $40.68 $1.73 Million - $2.34 Million
57,421 Added 5.46%
1,109,684 $43.1 Million
Q1 2024

May 08, 2024
BUY
$26.56 - $33.55 $246,901 - $311,880
9,296 Added 0.89%
1,052,263 $33.9 Million
Q4 2023

Feb 06, 2024
BUY
$18.35 - $34.12 $5.07 Million - $9.43 Million
276,298 Added 36.04%
1,042,967 $29.9 Million
Q3 2023

Nov 08, 2023
BUY
$25.17 - $35.05 $1.4 Million - $1.95 Million
55,558 Added 7.81%
766,669 $21.2 Million
Q2 2023

Aug 09, 2023
BUY
$20.28 - $27.0 $1.09 Million - $1.45 Million
53,884 Added 8.2%
711,111 $19 Million
Q1 2023

May 11, 2023
BUY
$20.76 - $30.09 $1.95 Million - $2.83 Million
94,140 Added 16.72%
657,227 $14.2 Million
Q4 2022

Feb 13, 2023
BUY
$17.68 - $25.53 $401,601 - $579,913
22,715 Added 4.2%
563,087 $13.4 Million
Q3 2022

Nov 14, 2022
BUY
$17.46 - $26.0 $1.68 Million - $2.5 Million
95,969 Added 21.6%
540,372 $10.7 Million
Q2 2022

Aug 15, 2022
BUY
$14.54 - $27.17 $2,777 - $5,189
191 Added 0.04%
444,403 $8.66 Million
Q1 2022

May 13, 2022
BUY
$17.31 - $26.4 $227,349 - $346,737
13,134 Added 3.05%
444,212 $11.3 Million
Q4 2021

Feb 11, 2022
BUY
$24.35 - $33.7 $127,545 - $176,520
5,238 Added 1.23%
431,078 $10.9 Million
Q3 2021

Nov 16, 2021
BUY
$23.95 - $33.41 $1.7 Million - $2.37 Million
70,898 Added 19.97%
425,840 $11.7 Million
Q2 2021

Aug 16, 2021
BUY
$29.0 - $47.44 $1.16 Million - $1.9 Million
40,136 Added 12.75%
354,942 $11.3 Million
Q1 2021

May 17, 2021
BUY
$37.21 - $54.43 $1.78 Million - $2.6 Million
47,735 Added 17.87%
314,806 $14.4 Million
Q4 2020

Feb 16, 2021
BUY
$30.19 - $45.49 $76,441 - $115,180
2,532 Added 0.96%
267,071 $10.6 Million
Q3 2020

Nov 13, 2020
BUY
$22.61 - $34.8 $3.78 Million - $5.81 Million
167,008 Added 171.24%
264,539 $9.21 Million
Q2 2020

Aug 14, 2020
BUY
$19.65 - $39.34 $1.33 Million - $2.66 Million
67,650 Added 226.4%
97,531 $3.08 Million
Q1 2020

May 15, 2020
BUY
$20.0 - $34.08 $597,620 - $1.02 Million
29,881 New
29,881 $655,000

Others Institutions Holding RVMD

# of Institutions
278
Shares Held
161M
Call Options Held
260K
Put Options Held
620K
View Full List

About Revolution Medicines, Inc.

RVMD Quotes by TradingView
  • Ticker RVMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,697,600
  • Market Cap $3.77B
  • Description
  • Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...
More about RVMD
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email